Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Benninger-Döring

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Klinische Padiatrie|May 12, 2006
[Drug development in paediatric oncology]G Benninger-Döring, J Boos
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 10, 2006
[Non-commercial clinical trials--who will be the legal sponsor? Sponsorship of investigator-initiated clinical trials according to the German Drug Law]G Benninger-Döring, J Boos
Journal of Virology|October 10, 1998
Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytesS Pepperl, G Benninger-Döring, S Modrow, et al.
Virology|November 24, 1999
Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriersG Benninger-Döring, S Pepperl, L Deml, et al.
International Journal of Cancer|June 4, 1998
Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysisM Jäger, G Benninger-Döring, N Prang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Klinische Padiatrie|May 12, 2006
[Drug development in paediatric oncology]G Benninger-Döring, J Boos
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 10, 2006
[Non-commercial clinical trials--who will be the legal sponsor? Sponsorship of investigator-initiated clinical trials according to the German Drug Law]G Benninger-Döring, J Boos
Journal of Virology|October 10, 1998
Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytesS Pepperl, G Benninger-Döring, S Modrow, et al.
Virology|November 24, 1999
Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriersG Benninger-Döring, S Pepperl, L Deml, et al.
International Journal of Cancer|June 4, 1998
Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysisM Jäger, G Benninger-Döring, N Prang, et al.
Pageof 1